Related references
Note: Only part of the references are listed.Global Cancer Statistics, 2012
Lindsey A. Torre et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2015)
Apatinib for the treatment of gastric cancer
Ruixuan Geng et al.
EXPERT OPINION ON PHARMACOTHERAPY (2015)
Gastric Cancer: Descriptive Epidemiology, Risk Factors, Screening, and Prevention
Parisa Karimi et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2014)
Combining trastuzumab and cetuximab combats trastuzumab-resistant gastric cancer by effective inhibition of EGFR/ErbB2 heterodimerization and signaling
Lei Zheng et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2014)
Targeting Epithelial-to-Mesenchymal Transition with Met Inhibitors Reverts Chemoresistance in Small Cell Lung Cancer
Israel Canadas et al.
CLINICAL CANCER RESEARCH (2014)
Challenges in first line chemotherapy and targeted therapy in advanced gastric cancer
Marcelo Garrido et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2014)
1B50-1, a mAb Raised against Recurrent Tumor Cells, Targets Liver Tumor-Initiating Cells by Binding to the Calcium Channel α2δ1 Subunit
Wei Zhao et al.
CANCER CELL (2013)
The Noncoding RNA Expression Profile and the Effect of lncRNA AK126698 on Cisplatin Resistance in Non-Small-Cell Lung Cancer Cell
Yong Yang et al.
PLOS ONE (2013)
Molecular targeted therapy for advanced gastric cancer
Jong Gwang Kim
KOREAN JOURNAL OF INTERNAL MEDICINE (2013)
Role of autophagy in chemoresistance: Regulation of the ATM-mediated DNA-damage signaling pathway through activation of DNA-PKcs and PARP-1
Jung-Hoon Yoon et al.
BIOCHEMICAL PHARMACOLOGY (2012)
Drug Resistance: Challenges to Effective Therapy
M. P.V. Shekhar
CURRENT CANCER DRUG TARGETS (2012)
Heterogeneous Nuclear Ribonucleoprotein C1/C2 Controls the Metastatic Potential of Glioblastoma by Regulating PDCD4
Young Mi Park et al.
MOLECULAR AND CELLULAR BIOLOGY (2012)
A Gene Expression Signature of Acquired Chemoresistance to Cisplatin and Fluorouracil Combination Chemotherapy in Gastric Cancer Patients
Hark Kyun Kim et al.
PLOS ONE (2011)
Northwestern profiling of potential translation-regulatory proteins in human breast epithelial cells and malignant breast tissues: evidence for pathological activation of the IGF1R IRES
Scott W. Blume et al.
EXPERIMENTAL AND MOLECULAR PATHOLOGY (2010)
New insights into the mechanisms of gastric cancer multidrug resistance and future perspectives
Dexin Zhang et al.
FUTURE ONCOLOGY (2010)
Expression of P-glycoprotein and Multidrug Resistance-associated Protein is Associated with Multidrug Resistance in Gastric Cancer
H-W Xu et al.
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH (2010)
Recent advances in chemotherapy for advanced gastric cancer
Jong Gwang Kim et al.
WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY (2010)
Optimising treatment regimens for the management of advanced gastric cancer
R. Wong et al.
ANNALS OF ONCOLOGY (2009)
Impact of extended lymphadenectomy on morbidity, mortality, recurrence and 5-year survival after gastrectomy for cancer. Meta-analysis of randomized clinical trials
Suzana Angelica Silva Lustosa et al.
ACTA CIRURGICA BRASILEIRA (2008)
Interaction of heterogeneous nuclear ribonucleoprotein C1/C2 with a novel cis-regulatory element within p53 mRNA as a response to cytostatic drug treatment
Kyle J. Christian et al.
MOLECULAR PHARMACOLOGY (2008)
A proteomics approach for the identification of nucleophosmin and heterogeneous nuclear ribonucleoprotein C1/C2 as chromatin-binding proteins in response to DNA double-strand breaks
SY Lee et al.
BIOCHEMICAL JOURNAL (2005)
Proteome analysis of human hepatocellular carcinoma tissues by two-dimensional difference gel electrophoresis and mass spectrometry
CRMY Liang et al.
PROTEOMICS (2005)
Monoclonal antibodies as therapeutic agents for cancer
M Harris
LANCET ONCOLOGY (2004)
The use and analysis of microarray data
A Butte
NATURE REVIEWS DRUG DISCOVERY (2002)
Share Paper
